ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Chips and Earnings Drive Options Bets

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Tech earnings week is pulling options flow into semiconductors and mega-cap names. Micron Technology leads both positive and negative options bets over the past seven days. It sits at the top of the ORTEX options activity ranking by total value. Its RSI of 38 places it in oversold territory. Analysts see 78% upside from current levels.

Advanced Micro Devices appears in both the bullish and bearish top-10 lists. That split signals a market divided ahead of its Q3 results. AMD is up 141% year-to-date. The RSI sits at 39, also near oversold.

Meta Platforms draws heavy negative bets. It is down 2.7% year-to-date. Its RSI of 36 is the weakest of the three. Microsoft and Amazon also carry high two-sided options flow into this week's prints.

Tesla attracts the third-largest bullish options bet pool. ARK's comments about Tesla expanding into underground travel and electric aviation added fresh narrative fuel this morning. Tesla is down 17% year-to-date.

One outlier worth watching: Talen Energy reactor output fell 10 standard deviations below its own history as of 9 October, per ORTEX alt data. That is the sharpest deviation in the nuclear output dataset. Unusual operational readings like that can precede sharp moves in options pricing.

The dominant theme across markets is binary: earnings prints this week will resolve a broad tug-of-war between bulls and bears sitting in the same names.

Stocks in this article

How this article was generated

Generated
27 Oct 2026, 04:43
Prompt version
v1.0
Data sources
Options flowORTEX Alpha signalsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.